{"title": null, "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2002-01-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "COVID-19 en adultos con inmunodeficiencias humorales / COVID-19 in adults with antibody deficiencies\n[Medicina (B.Aires)](http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Medicina (B.Aires)); 81(3): 478-481, jun. 2021. graf\nArticle Dans Espagnol | LILACS | ID: biblio-1346490\nResponsable en Biblioth\u00e8que :\n[BR1.1](http://centros.bvsalud.org/?search=BR1.1&prefix=search&lang=fr)\nRESUMENResumen La\n[enfermedad] [COVID-19], causada por el [virus SARS-CoV-2], surgi\u00f3 a fines de 2019 en Wuhan, [China]. La [evoluci\u00f3n cl\u00ednica]es variable, as\u00ed como la [tasa de mortalidad], que es mayor en [pacientes]mayores de 65 a\u00f1os y en quienes padecen [enfermedades]subyacentes. Las inmunodeficiencias son potenciales [factores de riesgo]para formas graves de [COVID-19]. Los [pacientes]con inmunodeficiencias tienen adem\u00e1s mayor frecuencia de [complicaciones]no infecciosas, que podr\u00edan representar un [riesgo]adicional. Hasta el momento existen escasas [publicaciones]sobre [asociaci\u00f3n] [COVID-19]e inmunodeficiencias humorales. Considerando la importancia del estudio de esta nueva [enfermedad]viral y de su potencial repercusi\u00f3n en la [salud]de los pacien tes con inmunodeficiencias presentamos seis [casos]de [COVID-19]en [adultos]con d\u00e9ficit de [anticuerpos](tres [mujeres]y tres varones, edad promedio 48.5 a\u00f1os, rango 20-67). Cuatro ten\u00edan inmunodeficiencias primarias [inmunodeficiencia com\u00fan variable](n 3) y [agammaglobulinemia]ligada al [cromosoma X](n 1). Los otro dos ten\u00edan [hipogammaglobulinemia]secundaria, en un caso asociada a [timoma]( [s\u00edndrome]de Good), y en el otro a [tratamiento]con [rituximab]. La evoluci\u00f3n fue favorable en todos menos en el [paciente]con [s\u00edndrome]de Good, quien presentaba un marcado deterioro del [estado]general antes de contraer [COVID-19].\nABSTRACTAbstract COVID-19, caused by\n[SARS-CoV-2], emerged in late 2019 in Wuhan, [China]. Its [clinical course]is variable, as well as the mortality rate, which is higher among people over 65 years of age and [persons]with underlying conditions. Immunodeficiencies are po tential [risk factors]for severe forms of COVID-19. Furthermore, [patients]with immunodeficiencies often undergo non-infectious [complications], which could [bear]additional [risk]. So far, few [reports]of [patients]with COVID-19 and humoral immunodeficiencies have been published. Considering the importance of the study of this new [viral disease]and its potential [health]impact on [patients]with immunodeficiency disorders, we present six cases of COVID-19 in [patients]with impaired [humoral immunity]. Three were [women]and three were [men]. The average age was 48.5 years (range 20-67). Four had been diagnosed with primary antibody deficiency three had [common variable immunodeficiency]and one had X-linked [agammaglobulinemia]. The other two [patients]had [secondary] [hypogammaglobulinemia], one was associated with [thymoma](Good's [syndrome]), and the other was associated with [rituximab] [treatment]. The evolution was favorable in all except the [patient]with Good's [syndrome], [who]pre sented a marked decline in clinical status before contracting COVID-19.\nTexte int\u00e9gral: Disponible Indice: LILAS (Am\u00e9riques) Sujet Principal: Thymome / Tumeurs du thymus / Agammaglobulin\u00e9mie / Maladies d'immunod\u00e9ficience primaire / COVID-19 Type d'\u00e9tude: Facteurs de risque Limites du sujet: Adulte tr\u00e8s \u00e2g\u00e9 / Femelle / Humains / M\u00e2le langue: Espagnol Texte int\u00e9gral: Medicina (B.Aires) Th\u00e8me du journal: M\u00e9dicament Ann\u00e9e: 2021 Type: Article Pays d'affiliation: Argentine Institution/Pays d'affiliation: Hospital Brit\u00e1nico de Buenos Aires/AR / Hospital Dr Carlos G Durand/AR\nDocuments relatifs \u00e0 ce sujet\nMEDLINE\n...\nLILACS\nLIS", "language": null, "image": null, "pagetype": null, "links": ["#main_container", "#pesquisa", "#footer", "#", "#", "#", "#", "https://politicas.bireme.org/accesibilidad/en/", "https://www.globalindexmedicus.net/fr/", "javascript:change_language('ar')", "javascript:change_language('zh')", "javascript:change_language('en')", "javascript:change_language('fr')", "javascript:change_language('ru')", "javascript:change_language('es')", "javascript:change_language('pt')", "https://pesquisa.bvsalud.org/gim/advanced/?lang=fr", "https://www.globalindexmedicus.net/wp-content/themes/globalindexmedicus/img/guiafr.pdf", "#", "https://www.globalindexmedicus.net/", "https://pesquisa.bvsalud.org/gim/?lang=fr", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=au:\"L\u00f3pez, Ana Laura\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=au:\"Torre, Mar\u00eda Gabriela\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=au:\"Paolini, Mar\u00eda Virginia\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=au:\"Juri, Mar\u00eda Cecilia\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=au:\"Fern\u00e1ndez Romero, Diego S\"", "http://portal.revistas.bvs.br/transf.php?xsl=xsl/titles.xsl&xml=http://catserver.bireme.br/cgi-bin/wxis1660.exe/?IsisScript=../cgi-bin/catrevistas/catrevistas.xis|database_name=TITLES|list_type=title|cat_name=ALL|from=1|count=50&lang=pt&comefrom=home&home=false&task=show_magazines&request_made_adv_search=false&lang=pt&show_adv_search=false&help_file=/help_pt.htm&connector=ET&search_exp=Medicina (B.Aires)", "http://centros.bvsalud.org/?search=BR1.1&prefix=search&lang=fr", "https://www.facebook.com/sharer.php?u=https://pesquisa.bvsalud.org/gim/resource/fr/biblio-1346490", "https://twitter.com/intent/tweet?text=COVID-19 en adultos con inmunodeficiencias humorales https://pesquisa.bvsalud.org/gim/resource/fr/biblio-1346490", "https://www.linkedin.com/shareArticle?mini=true&url=https://pesquisa.bvsalud.org/gim/resource/fr/biblio-1346490&title=COVID-19 en adultos con inmunodeficiencias humorales - Index Medicus Global", "https://api.whatsapp.com/send?text=COVID-19 en adultos con inmunodeficiencias humorales - Index Medicus Global - https://pesquisa.bvsalud.org/gim/resource/fr/biblio-1346490", "#mark_ab_es", "#mark_ab_en", null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"Humains\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"M\u00e2le\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"Femelle\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"Adulte d'\u00e2ge moyen\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"Sujet \u00e2g\u00e9\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"Jeune adulte\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"Thymome\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"Tumeurs du thymus\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"Agammaglobulin\u00e9mie\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"Maladies d'immunod\u00e9ficience primaire\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"COVID-19\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=mh:\"SARS-CoV-2\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"COVID-19\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"COVID-19\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"Inmunodeficiencia primaria\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"Inmunodeficiencia secundaria\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"Primary immunodeficiency\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"SARS-CoV-2\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"SARS-CoV-2\"", "https://pesquisa.bvsalud.org/gim/?lang=fr&q=kw:\"Secondary immunodeficiency\"", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802021000300478", "javascript:window.print()", "javascript:export_xml_record('biblio-1346490');", "https://www.google.com/search?q=\"COVID-19 en adultos con inmunodeficiencias humorales\"", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802021000300478", "javascript:window.print()", "javascript:export_xml_record('biblio-1346490');", "https://www.google.com/search?q=\"COVID-19 en adultos con inmunodeficiencias humorales\"", "https://bvsalud.org/en/contact_us/", "http://politicas.bireme.org/terminos/en/", "http://politicas.bireme.org/privacidad/en/", "javascript:change_output('rss');", "javascript:;", "javascript:print_page();", "javascript:print_page(true);"]}